Quest to divest HemoCue diagnostic biz for about $300 million

02/25/2013 | RTT News

Radiometer Medical has agreed to acquire Quest Diagnostics' HemoCue business for about $300 million, plus cash balance adjustments, in a deal set to be finalized next month. HemoCue focuses on developing and marketing point-of-care diagnostics, including those used in glucose and hemoglobin testing.

View Full Article in:

RTT News

Published in Briefs:

SmartBrief Job Listings for Health Care